Exhibitors
Bayer
exhibitor_image
Decipher by Veracyte
Decipher Prostate delivers trusted genomic insights to help physicians and patients make confident, personalized treatment decisions across the prostate cancer continuum. Validated in over 90 peer-reviewed studies and 200,000 patients, this tissue-based test is a highly accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.
exhibitor_image
Novartis Pharmaceuticals Corporation
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Novocure
Regeneron
Teleflex, Inc
At Teleflex, we offer world-class interventional solutions for Urology, Including the UroLift treatment system for BPH and the Barrigel system for patients with prostate cancer undergoing radiation treatment.